LUCY (Innovative Eyewear) EBIT: $-8.96 Mil (TTM As of Mar. 2026)

What is Innovative Eyewear EBIT?

Innovative Eyewear LUCY +0.11% 56 EBIT is $-8.96 Mil as of Mar. 2026. GuruFocus rates LUCY with a GF Score™ of 56/100 and a GF Value™ of $1.82 (Possible Value Trap). The stock has 4 warning signs investors should review.

Innovative Eyewear's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $-2.37 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $-8.96 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Innovative Eyewear's annualized ROC % for the quarter that ended in Mar. 2026 was -353.30%. Innovative Eyewear's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -522.04%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Innovative Eyewear's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 1,107.91%.

Innovative Eyewear (NAS:LUCY) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Innovative Eyewear's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

	ROC % (Q: Mar. 2026 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2025 )	+	Invested Capital (Q: Mar. 2026 ))	/ count )
=	-9.488 * ( 1 - 0% )	/	( (2.644	+	2.727)	/ 2 )
=	-9.488	/	2.6855
=	-353.30 %

where

	Invested Capital		(Q: Dec. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	10.14	-	0.985	-	( 6.511	-	max(0, 1.045	-	9.435	+	6.511	))
=	2.644

	Invested Capital		(Q: Mar. 2026 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	9.48	-	1.076	-	( 5.677	-	max(0, 1.091	-	8.747	+	5.677	))
=	2.727

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Innovative Eyewear's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2026 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2025		Q: Mar. 2026
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-9.488	/	( ( (0.062 + max(1.544, 0))	+	(0.05 + max(1.979, 0)) )	/	2 )
=	-9.488	/	( ( 1.606	+	2.029 )	/	2 )
=	-9.488	/	1.8175
=	-522.04 %

where Working Capital is:

	Working Capital		(Q: Dec. 2025 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.142	+	1.745	+	0.702)	-	(0.985	+	0.06	+	0)
=	1.544

	Working Capital		(Q: Mar. 2026 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.072	+	1.405	+	1.593)	-	(1.076	+	0.015	+	0)
=	1.979

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Innovative Eyewear's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2026 )
	=	-8.963	/	-0.809
	=	1,107.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovative Eyewear EBIT Related Terms

Innovative Eyewear EBIT Historical Data

* Premium members only.

The historical data trend for Innovative Eyewear's EBIT can be seen below:

Innovative Eyewear EBIT Chart

Innovative Eyewear Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EBIT

Get a 7-Day Free Trial

-3.21

-5.58

-6.66

-7.92

-8.50

Innovative Eyewear Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EBIT	Get a 7-Day Free Trial															-1.90	-2.17	-1.92	-2.50	-2.37

LUCY vs CUPR, MHUAF, NXGL: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Innovative Eyewear's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovative Eyewear EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Innovative Eyewear's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Innovative Eyewear's EV-to-EBIT falls into.

Save Embed

56GF Score

Innovative Eyewear Inc LUCY

EBIT is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Innovative Eyewear EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.96 Mil.

Frequently Asked Questions Learn more about EBIT →

What does a EBIT of $-8.96 Mil mean?

Innovative Eyewear (LUCY) has a EBIT of $-8.96 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Innovative Eyewear.

Is Innovative Eyewear's EBIT too high?

Innovative Eyewear's current EBIT is $-8.96 Mil. Overall, Innovative Eyewear has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Innovative Eyewear's EBIT compare to CUPR and MHUAF?

Innovative Eyewear's EBIT of $-8.96 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT for a Medical Devices & Instruments company?

A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT mean?

A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Innovative Eyewear. Innovative Eyewear's current EBIT is $-8.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Innovative Eyewear stock overvalued right now?

Based on GuruFocus' analysis, Innovative Eyewear (LUCY) is currently considered Possible Value Trap. The stock's GF Value™ is $1.82, compared to a current price of $0.74 — trading 59.3% below its estimated fair value. The current EBIT is $-8.96 Mil. Innovative Eyewear's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT calculated?

EBIT is calculated from a company's financial statements. For Innovative Eyewear (LUCY), the current EBIT is $-8.96 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Innovative Eyewear (LUCY) Overvalued in 2026?

Based on GuruFocus' analysis, Innovative Eyewear stock appears to be undervalued. The current stock price of $0.74 is trading 59.3% below its estimated GF Value™ of $1.82. GuruFocus considers Innovative Eyewear to be Possible Value Trap.

Key valuation signals for LUCY:

EBIT: $-8.96 Mil
GF Value™: $1.82 vs. price of $0.74 (59.3% below fair value)
GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the LUCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Innovative Eyewear Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies CUPR MHUAF NXGL CBSC RSCF GCTK RGNT YBGJ ECIA BNGO ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST TSE:4543 XPAR:DIM

Address 11900 Biscayne Boulevard, Suite 630, North Miami, FL, USA, 33181

Website https://www.lucyd.co

Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.

56GF Score

Get the complete analysis for LUCY

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.74

Price

$1.82

GF Value

View LUCY Analysis

See EBIT data for all stocks →